← Back to feedRead original →
VERIFIEDET Finance·positive
Zydus Lifesciences to pursue acquisitions in specialty, rare diseases
AI Summary
- ·Zydus Lifesciences will acquire US firm Assertio Holdings for $166.40 million.
- ·The acquisition aims to establish a strong specialty oncology business in the US.
- ·The company reported robust financial growth for the fourth quarter of 2025-26 and announced a share buyback and dividend.